Derek DiRocco
InvestorPartner at RA Capital
Boston, Massachusetts
Writes $100K β $5M checks Β· typically $1.5M
FoundedDay One Biopharmaceuticals Holding Co LLCEvommuneMineralys TherapeuticsRivus Pharmaceuticals, Inc.
Experience
- RA Capital Management, L.P.Partnercurrent2020 β presentBoston, Massachusetts, United States
- RA Capital Management, L.P.Principal2017 β 2020Greater Boston Area
- RA Capital Management, L.P.Analyst2015 β 2017Boston, Massachusetts
- RA Capital Management, L.P.Associate2013 β 2015Boston, MA
- Mineralys Therapeutics, Inc.Directorcurrent2022 β present
- Bambusa TherapeuticsDirectorcurrent2025 β present
- EvommuneDirectorcurrent2024 β present
- Forward Therapeutics, Inc.Directorcurrent2023 β present
- Rivus PharmaceuticalsDirectorcurrent2022 β present
- Acrivon Therapeutics, Inc.Directorcurrent2021 β present
- Frontier MedicinesDirectorcurrent2021 β present
- Frontier MedicinesBoard Observer2019 β 2021
- Navigator Medicines, Inc.Board Observercurrent2024 β present
- Navigator Medicines, Inc.Director2024
- 89bioDirector2018 β 2025
- Interius BioTherapeuticsBoard Observer2021 β 2025
- Werewolf TherapeuticsDirector2021 β 2025
- IDRxDirector2024 β 2025
- Carmot Therapeutics, Inc.Board Observer2022 β 2023
- iTeos Therapeutics SADirector2020 β 2023
Education
- University of Washington - School of MedicinePhD, Pharmacology2004 β 2009
- College of the Holy CrossB.A., Biology1998 β 2002
Skills & more
+12 more
Western BlottingConfocal MicroscopyMolecular CloningFluorescence MicroscopyLifesciencesCell CulturePCRLaboratoryTissue CultureDrug DiscoveryGenomicsScientific WritingFrom Derek's professional profile.
Same school
Also attended University of Washington - School of Medicine10
+ 4 more
Also attended College of the Holy Cross29
+ 23 more
Shared employers
Also worked at Frontier Medicines2
Also worked at Navigator Medicines, Inc.1
Also worked at Carmot Therapeutics, Inc.1
Deals Β· 7
Stipple BioBoard seat
via RA Capital Β· filed Apr 2026 Β· $100.2M raise
Rivus Pharmaceuticals, Inc.Board seat
via RA Capital Β· filed Jan 2025 Β· $57M raise
EvommuneBoard seat
via RA Capital Β· filed Jan 2025 Β· $115.5M raise
Mineralys TherapeuticsBoard seat
via RA Capital Β· filed Jun 2022 Β· $118M raise
Acrivon TherapeuticsBoard seat
via RA Capital Β· filed Nov 2021 Β· $100M raise
Day One Biopharmaceuticals Holding Co LLCBoard seat
via RA Capital Β· filed Feb 2021 Β· $130M raise
Werewolf TherapeuticsBoard seat
via RA Capital Β· filed Jan 2021 Β· $72.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at RA Capital
Network5
Investors connected to Derek in public investor directories β a warm-intro map.























